CD33 Alzheimer's disease locus: altered monocyte function and amyloid biology

The Alzheimer Disease Neuroimaging Initiative, Bradshaw, Elizabeth M, Chibnik, Lori B, Keenan, Brendan T, Ottoboni, Linda, Raj, Towfique, Tang, Anna, Rosenkrantz, Laura L +10 more·2013·Nature Neuroscience
DOI 10.1038/nn.3435

Cited by (571)

Items 301–400 of 571

  1. Impacts of CD33 Genetic Variations on the Atrophy Rates of Hippocampus and Parahippocampal Gyrus in Normal Aging and Mild Cognitive Impairment
    Alzheimer’s Disease Neuroimaging Initiative, Wenying Wang, Ying Min Liu, Hui-Fu Wang, Lin Tan, Fu-Rong Sun, Chen‐Chen Tan, Chen-Chen Tan, Teng Jiang, Lan Tan et al. · 2016 · Molecular Neurobiology
  2. Trans -pQTL study identifies immune crosstalk between Parkinson and Alzheimer loci
    Gail Chan, Charles C. White, Phoebe A. Winn, Maria Cimpean, Joseph M. Replogle, Laura R. Glick, Nicole Cuerdon, Katie J. Ryan, Keith A. Johnson, Julie A. Schneider et al. · 2016 · Neurology Genetics
  3. Association of blood-based transcriptional risk scores with biomarkers for Alzheimer disease
    Young Ho Park, Angela Hodges, Andrew Simmons, Simon Lovestone, Michael Walter Weiner, SangYun Kim, Andrew J. Saykin, Kwangsik T. Nho · 2020 · Neurology Genetics
  4. MAC2 is a long‐lasting marker of peripheral cell infiltrates into the mouse CNS after bone marrow transplantation and coronavirus infection
    Lindsay A. Hohsfield, Kate Inman Tsourmas, Yasamine Ghorbanian, Amber R. Syage, Sung Jin Kim, Yuting Cheng, Susana Furman, Matthew A. Inlay, Thomas E. Lane, Kim N. Green · 2022 · Glia
  5. The Association of Mid- and Late-Life Systemic Inflammation with Brain Amyloid Deposition: The ARIC-PET Study
    Keenan A. Walker, Beverly Gwen Windham, Charles H. Brown, David S. Knopman, Clifford R. Jack, Thomas H. Mosley, Elizabeth Selvin, Dean Foster Wong, Timothy M. Hughes, Yun Zhou et al. · 2018 · Journal of Alzheimer s Disease
  6. Tensor decomposition of stimulated monocyte and macrophage gene expression profiles identifies neurodegenerative disease-specific trans-eQTLs
    Satesh Ramdhani, Elisa Navarro, Evan Udine, Anastasia G. Efthymiou, Brian M. Schilder, Madison Parks, Alison Goate, Towfique Raj · 2020 · PLoS Genetics
  7. The age-related microglial transformation in Alzheimer's disease pathogenesis
    Chunxu Yuan, Ailikemu Aierken, Zhen Xie, Nuomin Li, Juan Zhao, Hong Qing · 2020 · Neurobiology of Aging
  8. Everolimus (RAD001) ameliorates vascular cognitive impairment by regulating microglial function via the mTORC1 signaling pathway
    Li Chen, Yanjun Zhang, Daojing Li, Nong Zhang, Ruiqiong Liu, Bin Han, Changjuan Wei, Haijie Liu, Xiaolin Xu, Junwei Hao · 2016 · Journal of Neuroimmunology
  9. Alzheimer’s Disease Genetics: Review of Novel Loci Associated with Disease
    M. Tábuas-Pereira, I. Santana, R. Guerreiro, J. Bras · 2020 · Current Genetic Medicine Reports
  10. Differential compartmentalization of myeloid cell phenotypes and responses towards the CNS in Alzheimer’s disease
    Fernández Zapata, Camila, Giacomello, Ginevra, Spruth, Eike J., Middeldorp, Jinte, Gallaccio, Gerardina, Dehlinger, Adeline, Dames, Claudia, Leman, Julia K. H., van Dijk, Roland E., Meisel, Andreas et al. · 2022 · Nature Communications
  11. Anti-neuroinflammatory effects of a food-grade phenolic-enriched maple syrup extract in a mouse model of Alzheimer’s disease
    Kenneth N. Rose, Benjamin J. Barlock, Nicholas A. DaSilva, Shelby L. Johnson, Chang Liu, Hang Ma, Robert B. Nelson, Fatemeh Akhlaghi, Navindra Persaud Seeram · 2019 · Nutritional Neuroscience
  12. Landscape of immune infiltration in entorhinal cortex of patients with Alzheimerʼs disease
    Hui Zhang, Silu Cao, Yaru Xu, Xiaoru Sun, Miaomiao Fei, Qi Jing, Xiaodong Xu, Jinxuan Tang, Bing Niu, Cheng Li · 2022 · Frontiers in Pharmacology
  13. Glia: guardians, gluttons, or guides for the maintenance of neuronal connectivity?
    Joseph D. Jebelli, Wei Su, Stephanie Hopkins, Jennifer M. Pocock, Gwenn A. Garden · 2015 · Annals of the New York Academy of Sciences
  14. Unraveling the genes implicated in Alzheimer's disease
    Mohan Giri, Abhilasha Shah, Bibhuti Upreti, Jayanti Chamling Rai · 2017 · Biomedical Reports
  15. Genome-wide significant risk factors on chromosome 19 and the APOE locus
    Sonia Moreno–Grau, Alzheimer’s Disease Neuroimaging Initiative, Isabel Hernández, Stefanie Heilmann‐Heimbach, Susana Ruiz, Maitée Rosende‐Roca, Ana Mauleón, Liliana Vargas, Octavio Rodríguez‐Gómez, Montserrat Alegret et al. · 2018 · Oncotarget
  16. Immune dysfunction in Alzheimer disease
    Oleg Butovsky, Neta Rosenzweig, Kilian L. Kleemann, Mehdi Jorfi, Vijay Kumar Kuchroo, Rudolph E. Tanzi, Howard L. Weiner · 2025 · Nature reviews. Neuroscience
  17. Heart and Brain: Complex Relationships for Left Ventricular Dysfunction
    Gianlorenzo Daniele, Stephanie DiLucia, Pier Giorgio Masci, Federica del Monte · 2020 · Current Cardiology Reports
  18. Novel TREM2 splicing isoform that lacks the V-set immunoglobulin domain is abundant in the human brain
    Kostantin Kiianitsa, Irina Kurtz, Neal E. Beeman, Mark M. Matsushita, Wei‐Ming Chien, Wendy H. Raskind, Olena Korvatska · 2021 · Journal of Leukocyte Biology
  19. Ellagic Acid Modulates the Amyloid Precursor Protein Gene via Superoxide Dismutase Regulation in the Entorhinal Cortex in an Experimental Alzheimer’s Model
    Wafaa S. Ramadan, Saleh Alkarim · 2021 · Cells
  20. Let’s make microglia great again in neurodegenerative disorders
    Marie‐Victoire Guillot‐Sestier, Terrence Town · 2017 · Journal of Neural Transmission
  21. Hippocampal formation alterations differently contribute to autobiographic memory deficits in mild cognitive impairment and Alzheimer's disease
    Dušan Hirjak, Robert Christian Wolf, Barbara Remmele, Ulrich Seidl, A Thomann, Katharina Maria Kubera, Johannes Schröder, Klaus Hermann Maier-Hein, Philipp Arthur Thomann · 2017 · Hippocampus
  22. Does the CD33 rs3865444 Polymorphism Confer Susceptibility to Alzheimer’s Disease?
    Vasileios Siokas, Paraskevi Aslanidou, Athina‐Maria Aloizou, Eleni Peristeri, Polyxeni Stamati, Ioannis Liampas, Stylianos Arseniou, Nikolaos Drakoulis, Michael Aschner, Aristidis Michael Tsatsakis et al. · 2020 · Journal of Molecular Neuroscience
  23. Inhibition of Smad3 in macrophages promotes Aβ efflux from the brain and thereby ameliorates Alzheimer's pathology
    Lu Xu, Cailong Pan, Xiang‐Hui Wu, Jingjing Song, Ping Meng, Lei Li, Li Wang, Zhiren Zhang, Zhi-Yuan Zhang · 2021 · Brain Behavior and Immunity
  24. The pollutome-connectome axis: a putative mechanism to explain pollution effects on neurodegeneration
    Lorenzo Pini, Alessandro Salvalaggio, Alexandra M. V. Wennberg, Anastasia Dimakou, Michela Matteoli, Maurizio Corbetta · 2023 · Ageing Research Reviews
  25. Mechanisms Underlying the Selection and Function of Macrophage-Specific Enhancers
    Verena M. Link, David Gosselin, Christopher K. Glass · 2015 · Cold Spring Harbor Symposia on Quantitative Biology
  26. The role of macrophage plasticity in neurodegenerative diseases
    Hongyue Ma, Mingxia Zhu, Mengjie Chen, Xiuli Li, Xinhong Feng · 2024 · Biomarker Research
  27. Siglecs as modulators of macrophage phenotype and function
    Emily N. Kukan, Gabrielle L Fabiano, Brian A. Cobb · 2024 · Seminars in Immunology
  28. Microglia-Mediated Phagocytosis in Alzheimer’s Disease: Mechanisms, Heterogeneity, and Therapeutic Insights
    Halimatu Hassan, Charlotte Rawlinson, Yu‐Long Lan, Stuart Iain Jenkins, Ruoli Chen · 2025 · Biomolecules
  29. Decreased cortical FADD protein is associated with clinical dementia and cognitive decline in an elderly community sample
    Alfredo Ramos‐Miguel, Jesús A. Garcı́a-Sevilla, Alasdair M. Barr, Thomas A. Bayer, Peter Falkai, Sue E. Leurgans, Julie A. Schneider, David Alan Bennett, William G. Honer, María Julia García-Fuster · 2017 · Molecular Neurodegeneration
  30. Association of CD33 and MS4A cluster variants with Alzheimer’s disease in East Asian populations
    Yanfang Mao, Zhangyu Guo, Jiali Pu, Yan‐Xing Chen, Baorong Zhang · 2015 · Neuroscience Letters
  31. Association between Single-Nucleotide Polymorphisms of the hOGG1,NEIL1,APEX1, FEN1,LIG1, and LIG3 Genes and Alzheimer's Disease Risk
    Dominik Kwiatkowski, Piotr Lech Czarny, Monika Maria Toma, Anna Imiela, Katarzyna Sowinska, Piotr Gałecki, Agnieszka Bachurska, Anna Bielecka-Kowalska, Janusz Szemraj, Michael H. J. Maes et al. · 2016 · Neuropsychobiology
  32. Protein and Peptides for Elderly Health
    Nan Shang, Meram Chalamaiah, Nandika Bandara, Jianping Wu · 2018 · Advances in protein chemistry and structural biology
  33. DNA Repair Inhibition Leads to Active Export of Repetitive Sequences to the Cytoplasm Triggering an Inflammatory Response
    Song, Xuan, Aw, Jacqueline T. M., Ma, Fulin, Cheung, Ming Fung, Leung, Danny, Herrup, Karl · 2021 · The Journal of Neuroscience
  34. Microglia rely on SYK signalling to mount neuroprotective responses in models of Alzheimer's disease and multiple sclerosis
    Hannah E. Ennerfelt, John R. Lukens · 2023 · Clinical and Translational Medicine
  35. Mind Gaps and Bone Snaps: Exploring the Connection Between Alzheimer’s Disease and Osteoporosis
    Hannah S. Wang, Sonali Jayant Karnik, Tyler J. Margetts, Lilian Irene Plotkin, Alexandru Movilă, Jill C. Fehrenbacher, Melissa A. Kacena, Adrian L. Oblak · 2024 · Current Osteoporosis Reports
  36. Inverse Relationship Between Alzheimer’s Disease and Cancer: How Immune Checkpoints Might Explain the Mechanisms Underlying Age-Related Diseases
    Nicole K. Rogers, Cesar Romero, Carol D. SanMartín, Daniela P. Ponce, Felipe Salech, Mercedes Natalia López, María Alejandra Gleisner, Fabián Tempio, María Isabel Behrens · 2019 · Journal of Alzheimer s Disease
  37. Brain tocopherol levels are associated with lower activated microglia density in elderly human cortex
    Francisca A. de Leeuw, Julie A. Schneider, Sonal Agrawal, Sue E. Leurgans, Martha Clare Morris · 2020 · Alzheimer s & Dementia Translational Research & Clinical Interventions
  38. Therapeutic potential to target sialylation and SIGLECs in neurodegenerative and psychiatric diseases
    Jannis Wißfeld, Tawfik Abou Assale, Germán Cuevas-Ríos, Huan Liao, Harald Neumann · 2024 · Frontiers in Neurology
  39. Rollercoaster ride of kynurenines: steering the wheel towards neuroprotection in Alzheimer’s disease
    Radhika Sharma, Karan Razdan, Yashika Bansal, Anurag Kuhad · 2018 · Expert Opinion on Therapeutic Targets
  40. Future Directions in Imaging Neurodegeneration
    Joseph C. Masdeu · 2017 · Current Neurology and Neuroscience Reports
  41. Interaction between variants in CLU and MS4A4E modulates Alzheimer's disease risk
    Mark Ebbert, Kevin L. Boehme, Mark E. Wadsworth, Lyndsay A. Staley, Alzheimer’s Disease Neuroimaging Initiative, Shubhabrata Mukherjee, Paul K. Crane, Perry G. Ridge, John S. K. Kauwe · 2015 · Alzheimer s & Dementia
  42. γ-mangostin attenuates amyloid-β42-induced neuroinflammation and oxidative stress in microglia-like BV2 cells via the mitogen-activated protein kinases signaling pathway
    Chaojun Kong, Longfei Jia, Jianping Jia · 2022 · European Journal of Pharmacology
  43. Roles of Siglecs in neurodegenerative diseases.
    Jian-Jing Siew, Y. Chern, K. Khoo, Takashi Angata · 2022 · Molecular Aspects of Medicine
  44. The impact of increasing levels of blood C-reactive protein on the inflammatory loci SPI1 and CD33 in Alzheimer’s disease
    Jinghan Huang, Qiushan Tao, Ting Fang Alvin Ang, John J. Farrell, Congcong Zhu, Yixuan Wang, Thor D. Stein, Kathryn L. Lunetta, Joseph M. Massaro, Jesse B Mez et al. · 2022 · Translational Psychiatry
  45. CD33 (Siglec-3) Inhibitory Function: Role in the NKG2D/DAP10 Activating Pathway
    Trinidad Hernández‐Caselles, Rubén Corral-San-Miguel, Antonio J. Ruiz‐Alcaraz, Pilar García–Peñarrubia · 2019 · Journal of Immunology Research
  46. Effect of APOE and CD33 on Cognitive Decline
    Kathleen M. Hayden, Michael William Lutz, Maragatha N. Kuchibhatla, CASSANDRA M. GERMAIN, Brenda L. Plassman · 2015 · PLoS ONE
  47. CSF metabolites associated with biomarkers of Alzheimer’s disease pathology
    Ruocheng Dong, Qiongshi Lu, Hyunseung Kang, Ivonne Suridjan, Gwendlyn Kollmorgen, Norbert Wild, Yuetiva K. Deming, Carol Ann Van Hulle, Rozalyn M. Anderson, Henrik Zetterberg et al. · 2023 · Frontiers in Aging Neuroscience
  48. Immunophenotypes associated with bipolar disorder and lithium treatment
    Tai-Na Wu, Chau‐Shoun Lee, Bojian Wu, Hsiao‐Ju Sun, Chieh-Hsing Chang, Chunying Chen, Chih-Ken Chen, Lawrence Shih‐Hsin Wu, Andrew T. A. Cheng · 2019 · Scientific Reports
  49. Alzheimer’s Disease Genetics: A Dampened Microglial Response?
    Zena K. Chatila, Elizabeth M. Bradshaw · 2021 · The Neuroscientist
  50. Structural Covariance Network as an Endophenotype in Alzheimer’s Disease-Susceptible Single-Nucleotide Polymorphisms and the Correlations With Cognitive Outcomes
    Hsin‐I Chang, Yu‐Tzu Chang, Chi‐Wei Huang, Kuo‐Lun Huang, Jung‐Lung Hsu, Shih‐Wei Hsu, Shih‐Jen Tsai, Wen‐Neng Chang, Chen‐Chang Lee, Shu‐Hua Huang et al. · 2021 · Frontiers in Aging Neuroscience
  51. Genome-wide significant, replicated and functional risk variants for Alzheimer’s disease
    Xiaoyun Guo, Wenying Qiu, Rolando García-Milian, Xiandong Lin, Yong Zhang, Yuping Cao, Yunlong Tan, Zhiren Wang, Jing Shi, Jijun Wang et al. · 2017 · Journal of Neural Transmission
  52. In Alzheimer-prone brain regions, metabolism and risk-gene expression are strongly correlated
    Fengdan Ye, Quentin Funk, Elijah Rockers, Joshua M Shulman, Joseph C. Masdeu, Belén Pascual, Alzheimer’s Disease Neuroimaging Initiative · 2022 · Brain Communications
  53. The β‐adrenergic hypothesis of synaptic and microglial impairment in Alzheimer's disease
    Shaomin Li · 2023 · Journal of Neurochemistry
  54. Integration of multiscale dendritic spine structure and function data into systems biology models
    James J. Mancuso, Jie Cheng, Zheng Yin, Jared C. Gilliam, Xiaofeng Xia, Xuping Li, Stephen T. C. Wong · 2014 · Frontiers in Neuroanatomy
  55. Proteomic signatures of neuroinflammation in Alzheimer’s disease, multiple sclerosis and ischemic stroke
    Camilla Thygesen, Martin R. Larsen, Bente R. Finsen · 2019 · Expert Review of Proteomics
  56. Stem cell-based therapy as a promising approach in Alzheimer's disease: current perspectives on novel treatment
    Saeid Bagheri‐Mohammadi · 2021 · Cell and Tissue Banking
  57. Decreased expression of CD33 in peripheral mononuclear cells of Alzheimer's disease patients
    Nan Hu, Meng‐Shan Tan, Lei Sun, Teng Jiang, Yingli Wang, Lin Tan, Wei Zhang, Jin‐Tai Yu, Lan Tan · 2014 · Neuroscience Letters
  58. Cell-Type-Specific Gene Modules Related to the Regional Homogeneity of Spontaneous Brain Activity and Their Associations With Common Brain Disorders
    Junlin Shen, Bingbing Yang, Zhonghua Xie, Heng Wu, Zhanye Zheng, Jianhua Wang, Ping Wang, Peng Zhang, Wei Li, Zhaoxiang Ye et al. · 2021 · Frontiers in Neuroscience
  59. In Vivo Phagocytosis Analysis of Amyloid Beta
    Darío Tejera, Michael Thomas Heneka · 2019 · Methods in molecular biology
  60. Glial Cells in the Early Stages of Neurodegeneration: Pathogenesis and Therapeutic Targets
    Eugenia A. Ahremenko, Alexander Andreev, Danila Apushkin, Eduard Korkotian · 2025 · International Journal of Molecular Sciences
  61. CARD9 attenuates Aβ pathology and modifies microglial responses in an Alzheimer’s disease mouse model
    Hannah E Ennerfelt, Coco Holliday, Daniel A. Shapiro, Kristine E. Zengeler, Ashley C. Bolte, T. Ulland, John R. Lukens · 2023 · Proceedings of the National Academy of Sciences of the United States of America
  62. Monocytes release cystatin F dimer to associate with Aβ and aggravate amyloid pathology and cognitive deficits in Alzheimer’s disease
    Qiang Li, Bing Li, Li Liu, Kang-Ji Wang, Mingyue Liu, Yu Deng, Ze Li, Wei‐Dong Zhao, Liyong Wu, Yuhua Chen et al. · 2024 · Journal of Neuroinflammation
  63. Drugs for Targeted Therapies of Alzheimer’s Disease
    Chit Tam, Jack Ho Wong, Tzi Bun Ng, Stephen Kwok‐Wing Tsui, Tao Zuo · 2018 · Current Medicinal Chemistry
  64. Association of MS4A6A, CD33, and TREM2 gene polymorphisms with the late-onset Alzheimer’s disease
    Elham Mehdizadeh, Mohammad Khalaj‐Kondori, Zeinab Shaghaghi-Tarakdari, Saeed Sadigh‐Eteghad, Mahnaz Talebi, Sasan Andalib · 2019 · Bioimpacts
  65. Amyloids in Site-Specific Autoimmune Reactions and Inflammatory Responses
    Yanmei Huang, Xuezhi Hong, Jian Xing Shen, Li-Jun Geng, Yan-Hong Pan, Wei Ling, Hai‐Lu Zhao · 2020 · Frontiers in Immunology
  66. Reporter cell assay for human CD33 validated by specific antibodies and human iPSC-derived microglia
    Jannis Wißfeld, Mona Mathews, Omar Mossad, Paola Picardi, Alessandro Cinti, Loredana Redaelli, Laurent Pradier, Oliver Brüstle, Harald Neumann · 2021 · Scientific Reports
  67. Functional dissection of CD33 locus implicates innate immune response in Alzheimer disease pathology
    Katy Malpass · 2013 · Nature Reviews Neurology
  68. Hypothesis: cerebrospinal fluid protein markers suggest a pathway toward symptomatic resilience to AD pathology
    Pierre‐François Meyer, Mélissa Savard, Judes Poirier, David Morgan, John C.S. Breitner, Alzheimer’s Disease Neuroimaging Initiative · 2019 · Alzheimer s & Dementia
  69. Microglial Expression of the Wnt Signaling Modulator DKK2 Differs between Human Alzheimer’s Disease Brains and Mouse Neurodegeneration Models
    N. Aghaizu, Sarah Jolly, Satinder K. Samra, B. Kalmar, K. Craessaerts, L. Greensmith, P. Salinas, B. de Strooper, P. Whiting · 2023 · eNeuro
  70. HuM195 and its single-chain variable fragment increase Aβ phagocytosis in microglia via elimination of CD33 inhibitory signaling
    Eitan Wong, Manish Malviya, Tanya Jain, George Paul Liao, Zoe Kehs, Jerry C. Chang, Lorenz Studer, David A. Scheinberg, Yue‐Ming Li · 2024 · Molecular Psychiatry
  71. Microglia signaling in health and disease – Implications in sex-specific brain development and plasticity
    Subrata Pramanik, Harini Devi M., Saswata Chakrabarty, Berkay Paylar, Ajay Pradhan, Manisha Thaker, Shamini Ayyadhury, Arulmani Manavalan, Per‐Erik Olsson, Gopal Pramanik et al. · 2024 · Neuroscience & Biobehavioral Reviews
  72. Comprehensive investigation of multiple targets in the development of newer drugs for the Alzheimer's disease
    Patil Ashwini, Subhash L. Bodhankar, Amol Muthal, Dileep Kumar, Atmaram Pawar, Ravindra Kulkarni · 2024 · Acta Pharmaceutica Sinica B
  73. Microglial Modulation in Alzheimer’s Disease: Central Players in Neuroinflammation and Pathogenesis
    Md Sadique Hussain, Yumna Khan, Rabab Fatima, Mudasir Maqbool, Prasanna Srinivasan Ramalingam, Mohammad Gayoor Khan, Ajay Singh Bisht · 2025 · Current Alzheimer Research
  74. Alzheimer′s disease: Unique markers for diagnosis & new treatment modalities
    Neelum T. Aggarwal, Raj C. Shah, David A. Bennett · 2015 · The Indian Journal of Medical Research
  75. Neuroimaging of Diseases Causing Dementia
    Joseph C. Masdeu · 2019 · Neurologic Clinics
  76. Common determinants of severe Covid-19 infection are explicable by SARS-CoV-2 secreted glycoprotein interaction with the CD33-related Siglecs, Siglec-3 and Siglec-5/14
    SIMON H MURCH · 2020 · Medical Hypotheses
  77. Genetics of neuropsychiatric symptoms in patients with Alzheimer's disease: A 1‐year follow‐up study
    Mei‐Feng Huang, Wei‐Ju Lee, Yi‐Chun Yeh, Yi‐Chu Liao, Shuu‐Jiun Wang, Yi‐Hsin Yang, Cheng‐Sheng Chen, Jong‐Ling Fuh · 2020 · Psychiatry and Clinical Neurosciences
  78. Multitasking Microglia and Alzheimer’s Disease: Diversity, Tools and Therapeutic Targets
    Alexandra Grubman, Katja M. Kanninen, Tarja Malm · 2016 · Journal of Molecular Neuroscience
  79. Carriers of the p.P522R variant in PLCγ2 have a slightly more responsive immune system
    Diks, Annieck M., Teodosio, Cristina, de Mooij, Bas, Groenland, Rick J., Naber, Brigitta A. E., de Laat, Inge F., Vloemans, Sandra A., Rohde, Susan, de Jonge, Marien I., Lorenz, Linda et al. · 2023 · Molecular Neurodegeneration
  80. Recent Trends in Active and Passive Immunotherapies of Alzheimer’s Disease
    Meshal Alshamrani · 2023 · Antibodies
  81. Microglial modulation as a therapeutic strategy in Alzheimer's disease: Focus on microglial preconditioning approaches
    Younes Yassaghi, Yasaman Nazerian, Mobina Ghasemi, Amirhossein Nazerian, Fatemeh Sayehmiri, George L. Perry, Hamid Gholami Pourbadie · 2024 · Journal of Cellular and Molecular Medicine
  82. Does the Interplay Between Aging and Neuroinflammation Modulate Alzheimer’s Disease Clinical Phenotypes? A Clinico-Pathological Perspective
    Ricardo Jorge Ferreira Taipa, Ana Luísa Sousa, Manuel Melo Pires, Nuno Sousa · 2016 · Journal of Alzheimer s Disease
  83. Neuroinflammation, Type 2 Diabetes, and Dementia
    Connie H. Y. Wong, Brooke J. Wanrooy, David G. Bruce · 2018 · Elsevier eBooks
  84. Fighting fire with fire: The immune system might be key in our fight against Alzheimer’s disease
    Pieter Dujardin, Roosmarijn E. Vandenbroucke, Lien Van Hoecke · 2022 · Drug Discovery Today
  85. CD33 rs3865444 as a risk factor for Parkinson’s disease
    Vasileios Siokas, Stylianos Arseniou, Athina‐Maria Aloizou, Zisis Tsouris, Ioannis Liampas, Markos N. Sgantzos, Panagiotis Liakos, Dimitrios Petrou Bogdanos, Georgios M. Hadjigeorgiou, Efthimios Dardiotis · 2021 · Neuroscience Letters
  86. Platelet dysfunction in hypercholesterolemia mice, two Alzheimer’s disease mouse models and in human patients with Alzheimer’s disease
    Barbara Plagg, Josef Marksteiner, Kathrin Maria Kniewallner, Christian Humpel · 2015 · Biogerontology
  87. The role of peripheral innate immune cells in Alzheimer’s disease progression
    Yanchun Cao, Ke Tang, Pengcheng Ma, Run Zhang, Yani Yang, Tingting Li, Ying Zhang, Xiaoming Peng · 2025 · Frontiers in Immunology
  88. Recent developments in the role of DNA damage response and understanding its implications for new therapeutic approaches in Alzheimer's disease
    Rajesh Ranganathan, Georgy Sapozhnikov, Ni Wang, Siwen Li, You‐Qiang Song · 2023 · Translational Medicine of Aging
  89. Overexpression of TIPE2, a Negative Regulator of Innate and Adaptive Immunity, Attenuates Cognitive Deficits in APP/PS1 Mice
    Yongzhen Miao, Naidong Wang, Wenjin Shao, Zihan Xu, Zhihong Yang, Lei Wang, Chuanxia Ju, Ruoyu Zhang, Fang Zhang · 2019 · Journal of Neuroimmune Pharmacology
  90. Emerging roles for ITAM and ITIM receptor signaling in microglial biology and Alzheimer's disease‐related amyloidosis
    Joshua D. Samuels, John R. Lukens, Richard J. Price · 2023 · Journal of Neurochemistry
  91. Integration of Multilocus Genetic Risk into the Default Mode Network Longitudinal Trajectory during the Alzheimer’s Disease Process
    Fan Su, Hao Shu, Qing Ye, Chunming Xie, Baoyu Yuan, Zhijun Zhang, Feng Bai · 2016 · Journal of Alzheimer s Disease
  92. Bibliometric analysis of research on neurodegenerative diseases and single-cell RNA sequencing: Opportunities and challenges
    Wei Wang, Tianhua Li, Zheng Wang, Yaxin Yin, Sitao Zhang, Chaodong Wang, Xinli Hu, Shibao Lu · 2023 · iScience
  93. Functional insight into LOAD-associated microglial response genes
    Lauren A. Jonas, Tanya Jain, Yue‐Ming Li · 2022 · Open Biology
  94. GW5074 Increases Microglial Phagocytic Activities: Potential Therapeutic Direction for Alzheimer’s Disease
    Sarah M. Connor, Mamunur Rashid, Katie J. Ryan, Kruti Rajan Patel, Justin D. Boyd, Jennifer Smith, Wassim Elyaman, David Alan Bennett, Elizabeth M. Bradshaw · 2022 · Frontiers in Cellular Neuroscience
  95. Genetic Biomarkers in Alzheimer’s Disease
    Tasneem Khan · 2016 · Elsevier eBooks
  96. CD33 mRNA Has Elevated Expression Levels in the Leukocytes of Peripheral Blood in Patients with Late-Onset Alzheimer’s Disease
    Fatemeh Heidari, George Ansstas, Farzam Ajamian · 2021 · Gerontology
  97. A cortical immune network map identifies a subset of human microglia involved in Tau pathology
    Patrick, Ellis, Olah, Marta, Taga, Mariko, Klein, Hans-Ulrich, Xu, Jishu, White, Charles C, Felsky, Daniel, Gaiteri, Chris, Chibnik, Lori B, Mostafavi, Sara et al. · 2017
  98. Genetic variability in response to Aβ deposition influences Alzheimer’s risk
    Dervis A. M. Salih, Sevinç Bayram, Manuel Sebastian Guelfi, Regina Hertfelder Reynolds, Maryam Shoai, Mina Ryten, Jonathan Brenton, David Zhang, Mar Matarín, Juan Antonio Botía et al. · 2018 · bioRxiv (Cold Spring Harbor Laboratory)
  99. Interplay of Monocytes and T Lymphocytes in COVID-19 Severity
    Lindsey E. Padgett, Huy Q. Dinh, Serena Chee, Claire E. Olingy, Runpei Wu, Daniel J. Araujo, Pandurangan Vijayanand, Christian H. H. Ottensmeier, Catherine C. Hedrick · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  100. MS4A6A/Ms4a6d deficiency disrupts neuroprotective microglia functions and promotes inflammation in Alzheimer’s disease model
    Haishan Jiao, Yi‐Jun Ge, Liang-Yu Huang, Ying Liu, Bang‐Sheng Wu, Piaopiao Lian, Yizhe Hao, Shanshan Han, Yiting Li, Kaimin Wu et al. · 2025 · Molecular Neurodegeneration